Page /
This article presents an evidence-based and clinically informed approach to the use of Leucovorin in children with autism spectrum disorders (ASD). It explores the role of folate pathway disruptions, including folate receptor autoantibodies, and how targeted supplementation may support cognitive and behavioral outcomes. Clinicians and families will find insights into the research, clinical protocols, and real-world considerations for implementing this therapy.
